scholarly journals Retrospective Evaluation of the Results of Women Patients of Childbearing Age Investigated at a Microbiology Laboratory for Screening Toxoplasma gondii, in Antalya

2012 ◽  
Vol 36 (2) ◽  
pp. 96-99 ◽  
Author(s):  
Nilufer Pekinturk ◽  
Yesim Cekin ◽  
Nilgun Gur



Parasite ◽  
2020 ◽  
Vol 27 ◽  
pp. 2 ◽  
Author(s):  
Daniela Fanigliulo ◽  
Serena Marchi ◽  
Emanuele Montomoli ◽  
Claudia Maria Trombetta

Toxoplasmosis is a worldwide health problem. Infection in pregnant women can result in severe fetal morbidity or in subclinical neonatal infection; most subclinical cases develop ocular and neurological sequelae. The purpose of this serological study was to assess the prevalence of Toxoplasma gondii in two populations of women of childbearing age in Siena (Tuscany, Central Italy) and Bari (Apulia, Southern Italy) between 2013 and 2017 and in a group of pregnant women in Bari in 2016–2017. Serum samples were tested for the presence of specific anti-Toxoplasma gondii IgG antibodies by a commercially available ELISA test. The percentage of seropositive subjects in Bari was significantly higher than in Siena (22.4% vs. 12.4%) and an age-related trend was observed. A low prevalence of T. gondii infection (13.8%) was observed among the pregnant women tested. In addition to showing a significant difference between Central and Southern Italy, this study provides updated data on T. gondii seroprevalence in women during childbearing age and pregnancy. The results confirm a trend toward a decrease, especially in younger people and pregnant women.



2013 ◽  
Vol 142 (8) ◽  
pp. 1661-1670 ◽  
Author(s):  
F. NOGAREDA ◽  
Y. LE STRAT ◽  
I. VILLENA ◽  
H. DE VALK ◽  
V. GOULET

SUMMARYToxoplasmosis is a worldwide zoonosis due to Toxoplasma gondii, a ubiquitous protozoan parasite of warm-blooded animals including humans. In pregnant women, primary infection can cause congenital toxoplasmosis resulting in severe malformations in the newborn. Since 1978, public health authorities in France have implemented a congenital toxoplasmosis prevention programme, including monthly serological screening of all seronegative pregnant women, and treatment in case of seroconversion. However, this programme does not produce systematic surveillance data on incidence and prevalence. Our objective was to estimate the incidence and prevalence of T. gondii infection, and the incidence of seroconversion during pregnancy in women in France. We used a catalytic model to estimate incidence and prevalence of Toxoplasma infection between 1980 and 2020 in women of childbearing age. We used age- and time-specific seroprevalence data obtained from the National Perinatal Surveys (NPS) conducted in 1995, 2003 and 2010. We assumed that incidence depends both on age and calendar time, and can be expressed as the product of two unknown functions. We also estimated incidence of seroconversion during pregnancy in 2010 from the NPS and the National Surveillance of Congenital Toxoplasmosis (ToxoSurv). We combined data of 42208 women aged 15–45 years with serology available from the three NPS. For women aged 30 years the modelled incidence decreased from 7·5/1000 susceptible women in 1980 to 3·5/1000 in 2000. In 2010 the incidence was 2·4/1000. The predicted incidence and prevalence for 2020 was 1·6/1000 and 27%, respectively. The incidence of seroconversion during pregnancy in 2010 was estimated at 2·1/1000 susceptible pregnant women (95% CI 1·3–3·1) from the NPS and 1·9 (95% CI 1·8–2·1) from ToxoSurv. Incidence and prevalence of Toxoplasma infection has decreased markedly during the last 30 years. This decrease may be explained by a lower exposure to the parasite by changes in food habits and by improved hygiene practices in meat production. Modelled estimations were consistent with estimates observed in other studies conducted previously in France. The catalytic modelling provides reliable estimates of incidence and prevalence of Toxoplasma infection over time. This approach might be useful for evaluating preventive programme for toxoplasmosis.



Author(s):  
Mariza Martins Avelino ◽  
Dioclécio Campos Júnior ◽  
Josetti Barbosa de Parada ◽  
Ana Maria de Castro


Author(s):  
Ayşegül Çopur Çiçek ◽  
Fazilet Duygu ◽  
İbrahim Halil İnakçı ◽  
Nuray Boyar ◽  
İbrahim Hakan Boyar


2019 ◽  
Vol 10 (3) ◽  
pp. 1948-1952
Author(s):  
Fatima Ibrahim Mohammad ◽  
Mustafa Ali Abdul Ameer

The present study aims to detection Interleukin-6 gene polymorphism (-174 G/C) from seropositive Toxoplasma gondii pregnant women patients and healthy control from individuals reviewers to AL-Diwaniyah hospital. 80 samples were collected for the period from October 2018- April 2019, including two groups of 30 samples healthy control and 50 samples from pregnant women infected with Toxoplasma gondii. The results of the present study indicated the presence of IL-6 (-174 G/C) polymorphism in pregnant women infected with Toxoplasma gondii and healthy control. Where was observed that CG genotype more frequent in patients indicating the association of this genotype with the disease compared to the control group where CG genotype appears less. Also, the results of the current study indicate the appearance of allele C more frequently in pregnant women patients compared to healthy control. We can conclude from the present study there association of appearance allele C with Toxoplasma gondii infection.



2020 ◽  
Vol 6 (2) ◽  
pp. 163
Author(s):  
Ayfer Bakır ◽  
Mustafa Guney

Toxoplasmosis, despite its mild course in immunocompetent individuals, it may have a more severe course in immunosuppressed patients such as hematology and oncology patients. This study aimed to contribute to the importance of that issue by evaluating the seropositivity rates of Toxoplasma gondii (T. gondii) in Hematology and Oncology patients and sharing the data obtained. Serum samples sent from pediatric and adult Hematology/Oncology outpatient clinic to the Microbiology Laboratory between January 2017 and August 2019 were analysed using Architect Toxo IgG and IgM Reagent Kit with chemiluminescent microparticular enzyme immunoassay method on Architect system. A total of 673 patient samples belonging to 131 pediatric patients and 542 adult patients were analysed in the study. Median age of the study group was 29 (range: 0 - 83) and 53.5% of them were male. While T. gondii IgM positivity was 8% IgG positivity was 28.7%. T. gondii IgG seropositivities in male and female patients were 27.2% and 30.4% respectively (p = 0.44). T. gondii IgM seropositivities in pediatric and adult patients were 6.9% and 8.3% respectively and IgG seropositivities were 24.4% and 29.7% (p = 0.78 and p = 0.46 respectively). T. gondii IgM positivity was found as 8% and IgG positivity as 28.7% in the study group. In conclusion, data obtained from the study were in compliance with both domestic and foreign data and the highest rate of IgM and IgG seropositivity was found in patients with lymphoma.



2021 ◽  
Vol 6 (12) ◽  
pp. 98-103
Author(s):  
Meryem COLAK ◽  
Nergis ASGIN

Toxoplasmosis is a zoonotic infectious disease that is common worldwide and caused by the Toxoplasma gondii. Congenital toxoplasmosis is one of the major complications of this infection. The present study aimed to investigate T.gondii seroprevalence and evaluate the IgG avidity test results among childbearing- age women retrospectively. A total of 9401 samples obtained from childbearing -age (15-49 years of age) women who attended Karabuk University Training and Research Hospital between February 2016- January 2020, over the four-year, were included in the study.The Toxoplasma-IgM, Toxoplasma-IgG antibody, and Toxoplasma IgG avidity tests were analyzed chemiluminescent method by using ARCHITECT I 2000 SR immunoassay device (Abbott Laboratories, USA). Toxoplasma-IgM and Toxoplasma-IgG seropositivity were detected as 0.7% (67/9401) and 15.7% (1415/9005) respectively. A high percentage of Toxoplasma-IgM and Toxoplasma-IgG seropositivity were detected among 31-35 years of age group. The Toxoplasma seropositivity increased by age, but no statistically difference was found (P >0.05).The Toxoplasma IgG avidity was high in 45 patients (69.4%), low avidity was detected in 16 patients (22.6%) and from the remaining 6 patients were borderline (8%). The Toxoplasma IgM and IgG seropositivity rate decreased 2016 to 2020. The highest Toxoplasma IgM and IgG seropositivity were in 2016 with 1.2% and 16.8%, respectively. The T. gondi seropositivity rate was decreased from 2016 to 2020; it is probably a result of increasing awareness of the disease among patients. We think our results will contribute to the epidemiological data in our province and country and raise awareness.



2014 ◽  
Vol 44 (2) ◽  
pp. 329-342
Author(s):  
Ahmed Megahed Ahmed Saleh ◽  
Hisham Abd El-Raouf Ali ◽  
Salwa Abdalla Mohamed Ahmed ◽  
Samah Mostafa Hosny ◽  
Tosson A. Morsy


Sign in / Sign up

Export Citation Format

Share Document